Keywords: Meda, Edluar, Debiopharm, Ascepion Pharma, ASP-08126, Mallinckrodt, Horizon Pharma, Duexis

News briefs: Meda's Edluar; Debiopharm/Ascepion; Mallinckrodt/Horizon

Article | 19 June 2012

Print This

Swedish drugmaker Meda AB (OMX: MEDA A) says that is Edluar, an oral sublingual formulation of zolpidem, has received registration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in